Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?

Figure 3

Overall survival of combined patient population receiving adjuvant tamoxifen or chemotherapy according to the SULT1A1 rs9282861 genotype. The black solid line represents patients homozygous or heterozygous for the rs9282861 G allele and the black dotted line represents patients homozygous for the rs9282861 A allele. Adjustments were made for stage, age, radiation therapy, and hormone receptor status.

Back to article page